VANGUARD WHITEHALL FDS's ticker is VYM and the CUSIP is 921946406. A total of 1,313 filers reported holding VANGUARD WHITEHALL FDS in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,111,288 | +2.2% | 523,724 | +4.9% | 0.14% | +2.8% |
| Q2 2023 | $52,950,207 | +99417.4% | 499,199 | -1.0% | 0.14% | -9.0% |
| Q1 2023 | $53,207 | +2.8% | 504,373 | +5.5% | 0.16% | -6.6% |
| Q4 2022 | $51,744 | -99.8% | 478,179 | +48.1% | 0.17% | +36.1% |
| Q3 2022 | $30,636,000 | +3.0% | 322,859 | +10.4% | 0.12% | 0.0% |
| Q2 2022 | $29,743,000 | +5.5% | 292,457 | +16.4% | 0.12% | +15.1% |
| Q1 2022 | $28,194,000 | +18.5% | 251,169 | +18.4% | 0.11% | +5.0% |
| Q4 2021 | $23,788,000 | +15.7% | 212,188 | +6.7% | 0.10% | -5.6% |
| Q3 2021 | $20,554,000 | +25.0% | 198,880 | +26.7% | 0.11% | +4.9% |
| Q2 2021 | $16,447,000 | +0.5% | 156,983 | -3.0% | 0.10% | -10.5% |
| Q1 2021 | $16,359,000 | +8.6% | 161,811 | -1.7% | 0.11% | -1.7% |
| Q4 2020 | $15,058,000 | +11.4% | 164,555 | -1.4% | 0.12% | -8.7% |
| Q3 2020 | $13,513,000 | +2.6% | 166,972 | -0.1% | 0.13% | -3.8% |
| Q2 2020 | $13,167,000 | +0.7% | 167,136 | -9.5% | 0.13% | -19.0% |
| Q1 2020 | $13,073,000 | -8.0% | 184,776 | +21.8% | 0.16% | +10.1% |
| Q4 2019 | $14,215,000 | +3.9% | 151,695 | -1.7% | 0.15% | -9.8% |
| Q3 2019 | $13,687,000 | +80.7% | 154,255 | +77.9% | 0.16% | +82.2% |
| Q2 2019 | $7,575,000 | -18.6% | 86,693 | -20.2% | 0.09% | -32.3% |
| Q1 2019 | $9,305,000 | +95.4% | 108,624 | +78.0% | 0.13% | +56.5% |
| Q4 2018 | $4,761,000 | -4.1% | 61,040 | +7.1% | 0.08% | -33.6% |
| Q3 2018 | $4,965,000 | +10.8% | 57,007 | +5.7% | 0.13% | +0.8% |
| Q2 2018 | $4,480,000 | +18.5% | 53,943 | +17.7% | 0.13% | -6.6% |
| Q1 2018 | $3,781,000 | -3.0% | 45,836 | +0.7% | 0.14% | -9.9% |
| Q4 2017 | $3,899,000 | +65.8% | 45,531 | +57.0% | 0.15% | +42.5% |
| Q3 2017 | $2,352,000 | -2.5% | 29,007 | -6.0% | 0.11% | -7.0% |
| Q2 2017 | $2,413,000 | -1.4% | 30,868 | -2.1% | 0.11% | +6.5% |
| Q1 2017 | $2,447,000 | +37.2% | 31,517 | +33.9% | 0.11% | +30.5% |
| Q4 2016 | $1,784,000 | +4.6% | 23,544 | -0.4% | 0.08% | 0.0% |
| Q3 2016 | $1,706,000 | +11.8% | 23,644 | +10.7% | 0.08% | -1.2% |
| Q2 2016 | $1,526,000 | -48.6% | 21,351 | -50.3% | 0.08% | -52.8% |
| Q1 2016 | $2,968,000 | – | 42,989 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinsale Capital Group, Inc. | 386,418 | $40,767,083 | 29.74% |
| Operose Advisors LLC | 542,201 | $57,202,167 | 28.42% |
| SWISS RE LTD | 728,970 | $76,906,335 | 18.04% |
| Benchmark Wealth Management, LLC | 248,469 | $26,603,540 | 16.96% |
| Montis Financial, LLC | 206,289 | $21,763,541 | 16.84% |
| MARINO, STRAM & ASSOCIATES LLC | 486,254 | $51,299,789 | 15.49% |
| Coco Enterprises, LLC | 173,128 | $18,197,489 | 14.56% |
| ACT WEALTH MANAGEMENT, LLC | 227,565 | $24,008,106 | 14.28% |
| PARAGON FINANCIAL PARTNERS, INC. | 123,435 | $13,022,429 | 13.64% |
| CVS HEALTH Corp | 212,832 | $22,453,776 | 13.37% |